Nurse Practitioner, Family · Hartsville, SC
NPI
1740663038
Since 2015
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
1268 S 4th St
Hartsville, SC, 29550
Phone (843) 332-3422
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.2M
138,132 services
Medicare patients, 2024
176
Average age 71
Drug cost, 2024
$10.5M
10,476 prescriptions
Company payments, 2025
$2,890
From 36 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jennifer M Lynch was code J1439 (injection, ferric carboxymaltose, 1 mg), 22,500 times for 11 patients. In total Jennifer M Lynch billed 138,132 services in 65 codes, and Medicare paid $1.2M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-09-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 22,500 | 11 | $0.85 | $19K |
| J1306 Injection, inclisiran, 1 mg | Office | 4,544 | 12 | $9.51 | $43K |
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 1,005 | 16 | $0.23 | $230 |
| 96413 Chemotherapy Administration | Office | 236 | 55 | $75.49 | $18K |
| 96365 Intravenous Infusion, Hydration | Office | 197 | 36 | $37.58 | $7,403 |
| 96372 Injection Administration | Office | 117 | 38 | $8.29 | $970 |
| 96415 Chemotherapy Administration | Office | 116 | 19 | $15.55 | $1,803 |
| 96375 Injection Administration | Office | 101 | 34 | $3.05 | $308 |
| 81003 Clinical Chemistry | Office | 93 | 51 | $2.20 | $205 |
| 83036 Blood Count | Office | 90 | 47 | $9.52 | $857 |
| 82947 Clinical Chemistry | Office | 84 | 48 | $3.85 | $323 |
| 85018 Blood Count | Office | 71 | 19 | $2.08 | $148 |
| 96366 Intravenous Infusion, Hydration | Office | 68 | 22 | $11.36 | $772 |
| J1200 Injection, diphenhydramine hcl, up to 50 mg | Office | 55 | 16 | $0.60 | $33 |
| 87804 Immunoassay | Office | 51 | 18 | $16.22 | $827 |
By year: 2022 $81K for 5,631 services; 2023 $423K for 33,429 services; 2024 $1.2M for 138,132 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81003 Clinical Chemistry | 93 | 51 | $2.20 | $205 |
| 83036 Blood Count | 90 | 47 | $9.52 | $857 |
| 82947 Clinical Chemistry | 84 | 48 | $3.85 | $323 |
| 85018 Blood Count | 71 | 19 | $2.08 | $148 |
| 87804 Immunoassay | 51 | 18 | $16.22 | $827 |
| 36415 Venipuncture Blood Collection | 30 | 14 | $8.13 | $244 |
| 87426 Immunoassay | 26 | 19 | $34.62 | $900 |
Medicare prescription drug claims, 2024
In 2024, the drug Jennifer M Lynch prescribed most often to Medicare patients was Mounjaro (Tirzepatide), with 399 prescriptions and refills. In total Jennifer M Lynch wrote 10,476 Medicare prescriptions that cost $10.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Mounjaro Tirzepatide | 399 | 418 | 58 | $426K |
| Gabapentin Generic | 351 | 472 | 89 | $5,248 |
| Atorvastatin Calcium Generic | 350 | 992 | 125 | $3,171 |
| Amlodipine Besylate Generic | 311 | 816 | 110 | $1,753 |
| Levothyroxine Sodium Generic | 242 | 601 | 79 | $31K |
| Alprazolam Generic | 240 | 242 | 41 | $1,137 |
| Montelukast Sodium Generic | 178 | 446 | 61 | $1,102 |
| Pantoprazole Sodium Generic | 172 | 469 | 68 | $1,544 |
| Tramadol Hcl Generic | 147 | 147 | 31 | $1,964 |
| Cyclobenzaprine Hcl Generic | 147 | 179 | 42 | $1,841 |
| Omeprazole Generic | 141 | 378 | 51 | $2,404 |
| Lisinopril Generic | 139 | 404 | 51 | $812 |
| Furosemide Generic | 136 | 321 | 43 | $713 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 134 | 187 | 48 | $3,551 |
| Losartan Potassium Generic | 134 | 340 | 43 | $1,015 |
Brand drugs: 2,998 claims; generic drugs: 7,437 claims; opioid claims: 230.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jennifer M Lynch $2,890 ($2,890 in general payments such as food, travel and fees) from 36 companies. The largest payer was Abbvie Inc. with $497.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 35 | $497 |
| Amgen Inc. AMGN | 15 | $262 |
| Teva Pharmaceuticals USA, Inc. TEVA | 7 | $177 |
| Abbott Laboratories ABT | 9 | $159 |
| Novo Nordisk Inc NVO | 7 | $153 |
| Biogen, Inc. BIIB | 1 | $150 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 13 | $148 |
| Alnylam Pharmaceuticals Inc. ALNY | 2 | $147 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 5 | $106 |
| Lundbeck LLC | 4 | $90.56 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.